Pancreatic Cancer Research

ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaNo recent work listed

Carla Serra

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5555-0745; OpenAlex author ID A5025104089, A5103184461. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 8

  1. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre. Co-author DOI 10.1007/s13304-022-01346-x↗
  2. Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials. Co-author DOI 10.1097/sla.0000000000005126↗
  3. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience. Last author DOI 10.1007/s13304-020-00782-x↗
  4. Searching for novel multimodal treatments in oligometastatic pancreatic cancer. Co-author DOI 10.1186/s12885-020-06718-3↗
  5. Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. Co-author DOI 10.3892/ijo.2018.4344↗
  6. Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which… Co-author DOI 10.1007/s11605-015-2890-4↗
  7. Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array. Co-author DOI 10.3892/mmr.2015.4344↗
  8. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Co-author DOI 10.1159/000330291↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mariacristina Di Marco · 8 shared papers, 2011–2022 · strength 0.62
  2. Riccardo Casadei · 7 shared papers, 2015–2022 · strength 0.59
  3. Francesco Minni · 6 shared papers, 2015–2022 · strength 0.48
  4. Claudio Ricci · 6 shared papers, 2015–2021 · strength 0.47
  5. Carlo Ingaldi · 3 shared papers, 2020–2022 · strength 0.33
  6. Giovanni Brandi · 2 shared papers, 2020–2022 · strength 0.23
  7. Elisa Grassi · 3 shared papers, 2015–2020 · strength 0.21
  8. Daria Maria Filippini · 2 shared papers, 2018–2020 · strength 0.17
  9. Giorgio Ercolani · 2 shared papers, 2015–2020 · strength 0.15
  10. Deborah Malvi · 1 shared paper, 2022 · strength 0.12
  11. Claudio Ricci · 1 shared paper, 2022 · strength 0.12
  12. Guido Biasco · 2 shared papers, 2015–2018 · strength 0.10
  13. Michelle Lucinda DeOliveira · 1 shared paper, 2021 · strength 0.09
  14. Saskia Hussung · 1 shared paper, 2021 · strength 0.09
  15. Stefan Heinrich · 1 shared paper, 2021 · strength 0.09
  16. Dominique Lisa Birrer · 1 shared paper, 2021 · strength 0.09
  17. Thomas Baptist Brunner · 1 shared paper, 2021 · strength 0.09
  18. Pierre‐Alain Clavien · 1 shared paper, 2021 · strength 0.09
  19. Mickaël Lesurtel · 1 shared paper, 2021 · strength 0.09
  20. Henriette Golcher · 1 shared paper, 2021 · strength 0.09
  21. Robert Grützmann · 1 shared paper, 2021 · strength 0.09
  22. Ralph Fritsch · 1 shared paper, 2021 · strength 0.09
  23. Christiane J. Bruns · 1 shared paper, 2021 · strength 0.09
  24. Francesca Comito · 1 shared paper, 2018 · strength 0.06
  25. Antonio Maria Morselli‐Labate · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.